The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Ania Jastreboff, MD, PhD, is an Associate Professor in Medicine (Endocrinology & Metabolism) and Pediatrics (Pediatric Endocrinology) at Yale University School of Medicine, Director of Weight Management and Obesity Prevention at the Yale Stress Center, and co-Director of the Yale Center for Weight Management.
After completing a combined Internal Medicine and Pediatrics residency program, Dr. Jastreboff completed both an adult and a pediatric Endocrinology fellowship at Yale. During her dual fellowship, she also completed a PhD in the neurobiology of obesity, becoming board certified in Obesity Medicine, Adult Endocrinology, and Pediatric Endocrinology.
Dr. Jastreboff is a clinically active physician-scientist nationally and internationally recognized for helping to develop the 2016 Clinical Practice Guidelines for The Comprehensive Care of Patients with Obesity (AACE/ACE), educating the next generation of Obesity Medicine physicians by teaching annually at the Harvard Blackburn Treating Obesity course, the Columbia/Cornell Obesity course, selected international courses, and conducting cutting-edge clinical translational obesity research. Her research includes both large, multi-center clinical outcomes trials using anti-obesity medication as well as neuroimaging studies (fMRI and PET) examining the neurobiology underlying obesity and the mechanisms of anti-obesity medications. Dr. Jastreboff's research is supported by NIH/NIDDK (K23, R01s), American Diabetes Association (ADA), and industry funded multi-center clinical trials. Nationally, she serves as the vice-Chair of the Clinical Care Committee of The Obesity Society (TOS) and has been selected to serve as a Director on the American Board of Obesity Medicine (ABOM). Clinically, Dr. Jastreboff specializes in sophisticated use of anti-obesity medication combinations to help patients reach their weight and health goals!